Viridian Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 465.3% | 486.1% | 479.2% | 8,043.1% | – | 170.8% | – | – | – | 242.4% | 85.8% | 41.2% | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -142.4% | 100.0% | 100.0% | 99.6% | |
| 42,201.4% | 53,551.4% | 56,866.7% | 78,045.8% | 80,416.3% | 99,944.4% | 106,715.3% | 115,501.3% | 122.2% | 67,581.1% | 55,057.4% | 25,203.2% | 456.5% | |
| 29,043.1% | 45,823.6% | 20,868.1% | 22,313.9% | 16,753.5% | 21,644.4% | 23,754.2% | 26,954.7% | 34.5% | 25,510.6% | 27,431.9% | 19,357.4% | 213.2% | |
| 71,244.4% | 99,375.0% | 77,734.7% | 100,359.7% | 97,169.8% | 121,588.9% | 130,469.4% | 142,456.0% | 156.7% | 92,849.2% | 82,489.4% | 44,560.6% | 669.2% | |
| -71,144.4% | -99,275.0% | -77,634.7% | -100,259.7% | -97,069.8% | -121,488.9% | -130,369.4% | -142,356.0% | -56.7% | -92,991.7% | -82,389.4% | -44,460.6% | -569.7% | |
| 833.3% | 1,272.2% | 815.3% | 829.2% | 1,167.4% | 1,191.7% | 813.9% | 685.3% | 0.8% | 5,006.1% | 2,455.3% | 2,925.0% | 26.6% | |
| -66,194.4% | -92,861.1% | -67,419.4% | -90,268.1% | -89,173.3% | -110,729.2% | -120,711.1% | -134,313.3% | -49.0% | -91,178.0% | -74,397.9% | -44,760.2% | -544.1% | |
| -187.5% | 7,686.1% | -201.4% | 100,259.7% | – | – | – | – | – | – | – | – | – | |
| -66,194.4% | -92,861.1% | -67,419.4% | -90,268.1% | -89,173.3% | -110,729.2% | -120,711.1% | -134,313.3% | -49.0% | -91,178.0% | -74,397.9% | -44,760.2% | -544.1% | |
| -65,173.6% | -91,380.6% | -66,402.8% | -89,241.7% | -87,854.7% | -109,366.7% | -119,734.7% | -133,477.3% | -48.1% | -86,429.5% | -71,856.7% | -41,794.0% | -517.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.